Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up [13]

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1378-1379

  Beylot Barry, M ^a,b   Parrens, M ^b,c   Delaunay, M ^a   Thiebault, R ^d   Vergier, B ^b,c   DeMascarel, A ^c   Dubus, P ^c   Beylot, C ^a   Merlio, J P ^c  

^a HÔPITAL SAINT ANDRÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BONE MARROW BIOPSY; CANCER STAGING; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPHOCYTIC INFILTRATION; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEZARY SYNDROME; SKIN BIOPSY; SKIN INFILTRATE;

EID: 21644466447     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06621.x     Document Type: Letter

References (9)

1. Bunn PA, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep 1979; 63:725-8.
2. Kim YH, Liu HL, Mraz-Gernhard S et al. Long term outcome of 525 patients with mycosis fungoides and Sézary syndrome. Arch Dermatol 2003; 139:857-66.
3. Salhany KE, Greer JP, Cousar JB, Collins RD. Marrow involvement in cutaneous T-cell lymphoma. A clinicopathologic study of 60 cases. Am J Clin Pathol 1989; 92:747-54.
4. Diamandidou E, Colome M, Fayad L et al. Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 1999; 40:914-24.
5. Marti RM, Estrach T, Reverter JC et al. Utility of bone marrow and liver biopsies for staging cutaneous T-cell lymphoma. Int J Dermatol 1996; 35:450-4.
6. Marti RM, Estrach T, Reverter JC et al. Prognostic clinicopathologic factors in cutaneous T-cell lymphoma. Arch Dermatol 1991; 127:1511-16.
7. Zackheim HS, Amin S, Kashani-Sabet M et al. Prognosis in cutaneous T-cell lymphoma by skin stage: long term survival in 489 patients. J Am Acad Dermatol 1999; 40:418-25.
8. Sibaud V, Beylot-Barry M, Thiebaut R et al. Bone marrow histopathologic and molecular staging in epidermotropic T-cell lymphomas. Am J Clin Pathol 2003; 119:414-23.
9. Beylot-Barry M, Sibaud V, Thiebaut R et al. Evidence that an identical T-cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T-cell lymphomas. J Invest Dermatol 2001; 117:920-6. 1379-1381